Walleye Capital
TEVA icon

Walleye Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Walleye Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.8M Sell
59,600
-237,900
-80% -$7.65M 0.01% 1554
2025
Q4 		$9.28M Buy
297,500
+46,200
+18% +$1.14M 0.03% 708
2025
Q3 		$5.08M Buy
251,300
+110,900
+79% +$1.95M 0.02% 919
2025
Q2 		$2.35M Sell
140,400
-30,700
-18% -$495K 0.01% 1386
2025
Q1 		$2.63M Sell
171,100
-273,000
-61% -$4.88M 0.01% 1231
2024
Q4 		$9.79M Buy
444,100
+63,400
+17% +$1.15M 0.02% 642
2024
Q3 		$6.86M Buy
380,700
+104,900
+38% +$1.84M 0.01% 943
2024
Q2 		$4.48M Buy
275,800
+193,500
+235% +$2.98M 0.01% 1370
2024
Q1 		$1.16M Sell
82,300
-78,900
-49% -$995K ﹤0.01% 2443
2023
Q4 		$1.68M Buy
161,200
+82,500
+105% +$770K ﹤0.01% 1920
2023
Q3 		$803K Buy
78,700
+67,000
+573% +$624K ﹤0.01% 2439
2023
Q2 		$88.1K Buy
+11,700
New +$94.9K ﹤0.01% 3479
2022
Q4 		– Sell
-200
Closed -$2K – 3633
2022
Q3 		$2K Buy
+200
New +$1.77K ﹤0.01% 3067
2020
Q1 		– Sell
-175,000
Closed -$1.72M – 1639
2019
Q4 		$1.72M Sell
175,000
-55,300
-24% -$494K 0.11% 249
2019
Q3 		$1.58M Buy
230,300
+230,200
+230,200% +$1.76M 0.09% 287
2019
Q2 		$1K Sell
100
-39,400
-100% -$475K ﹤0.01% 1671
2019
Q1 		$619K Buy
+39,500
New +$697K 0.1% 311

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital's TEVA Position: Q1 2026 in Review

Walleye Capital opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 2,309 shares worth $69.5K. The stake represents ﹤0.01% of the portfolio and ranks #3800 among its holdings. This is a return to the name: Walleye Capital previously reported a position in TEVA as recently as Q3 2025.

Walleye Capital first reported a position in TEVA in Q1 2019 and has held it in 13 quarters since. The position peaked at $22.2M in Q4 2024. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Walleye Capital held 2,309 shares of Teva Pharmaceuticals worth $69.5K as of Q1 2026.
  • Teva Pharmaceuticals was a new Walleye Capital position in Q1 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3800 holding.
  • Walleye Capital first reported a position in Teva Pharmaceuticals in Q1 2019 and has held it in 13 quarters since.
  • Walleye Capital's Teva Pharmaceuticals position peaked at $22.2M in Q4 2024.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.